Helping individuals break free from nicotine addiction requires a tailored approach that addresses both physiological dependency and behavioral patterns. Smoking cessation and nicotine dependence remain critical topics in addiction medicine due to their high prevalence and significant health impacts. Interventions now blend pharmacologic aids—such as nicotine replacement therapy, bupropion, and varenicline—with behavioral counseling and digital health tools. Socioeconomic factors, mental health, and comorbid addictions can affect quit rates, highlighting the importance of comprehensive care models. Public policies on taxation, advertising, and smoking bans have also influenced cessation efforts. Research continues to explore genetic predispositions and relapse mechanisms to enhance outcomes.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States